Plain Language Summary of First-Line Amivantamab-Lazertinib in Previously Untreated High-Risk EGFR-altered Non-Small-cell Lung Cancer in MARIPOSA.
Future oncology (London, England)（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined